CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (CTMX)
CUSIP: 23284F105
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.00001 per share
- Shares outstanding
- 217,291,620
- Total 13F shares
- 50,687,257
- Share change
- +6,137,019
- Total reported value
- $61,863,474
- Put/Call ratio
- 103%
- Price per share
- $1.22
- Number of holders
- 73
- Value change
- +$334,609
- Number of buys
- 41
- Number of sells
- 50
Quarterly Holders Quick Answers
What is CUSIP 23284F105?
CUSIP 23284F105 identifies CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 23284F105:
Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
3%
|
6,595,801
|
$14,378,846 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
3%
|
6,450,000
|
$14,061,000 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.2%
|
4,857,374
|
$10,589,076 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.6%
|
3,544,578
|
$7,727,180 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.2%
|
2,690,830
|
$5,863,000 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.92%
|
2,000,000
|
$4,360,000 | — | 31 Mar 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.74%
|
1,598,590
|
$3,484,926 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.59%
|
1,274,507
|
$2,778,424 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.57%
|
1,232,800
|
$2,688,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.52%
|
1,131,208
|
$2,466,034 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.43%
|
936,778
|
$2,042,177 | — | 31 Mar 2024 | |
| Bronte Capital Management Pty Ltd. |
13F
|
Company |
0.42%
|
906,157
|
$1,975,422 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.39%
|
855,984
|
$1,866,045 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.35%
|
764,187
|
$1,665,928 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
753,398
|
$1,642,784 | — | 31 Mar 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.31%
|
679,403
|
$1,481,099 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.31%
|
671,628
|
$1,464,149 | — | 31 Mar 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.28%
|
600,000
|
$1,308,000 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.24%
|
529,935
|
$1,155,258 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
443,224
|
$966,228 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.19%
|
404,674
|
$882,189 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.14%
|
304,334
|
$663,448 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.14%
|
293,894
|
$640,689 | — | 31 Mar 2024 | |
| Tidal Investments LLC |
13F
|
Company |
0.13%
|
288,101
|
$630,941 | — | 31 Mar 2024 | |
| Formidable Asset Management, LLC |
13F
|
Company |
0.13%
|
288,101
|
$628,060 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.12%
|
267,476
|
$583,098 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.12%
|
253,773
|
$553,225 | — | 31 Mar 2024 | |
| BIT Capital GmbH |
13F
|
Company |
0.12%
|
250,910
|
$546,984 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
241,981
|
$527,519 | — | 31 Mar 2024 | |
| Congress Park Capital LLC |
13F
|
Company |
0.11%
|
233,800
|
$509,684 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.1%
|
210,151
|
$458,129 | — | 31 Mar 2024 | |
| Clearline Capital LP |
13F
|
Company |
0.09%
|
196,583
|
$428,551 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.09%
|
191,060
|
$416,511 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.08%
|
183,748
|
$400,571 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.08%
|
183,077
|
$399,108 | — | 31 Mar 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.07%
|
155,000
|
$337,900 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.07%
|
148,567
|
$324,000 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.07%
|
146,800
|
$320,024 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
134,118
|
$292,377 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.06%
|
133,199
|
$290,374 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.06%
|
123,653
|
$269,564 | — | 31 Mar 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.05%
|
107,700
|
$238,017 | — | 31 Mar 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.04%
|
92,315
|
$201,247 | — | 31 Mar 2024 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.04%
|
87,226
|
$190,153 | — | 31 Mar 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.04%
|
85,638
|
$186,691 | — | 31 Mar 2024 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
0.04%
|
81,352
|
$177,347 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
77,814
|
$169,634 | — | 31 Mar 2024 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.03%
|
69,179
|
$150,810 | — | 31 Mar 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.03%
|
56,745
|
$123,704 | — | 31 Mar 2024 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.03%
|
55,595
|
$121,197 | — | 31 Mar 2024 |
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (CTMX) as of Q2 2024
As of 30 Jun 2024,
CytomX Therapeutics, Inc. - Common Stock, par value $0.00001 per share (CTMX) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,687,257 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, JANUS HENDERSON GROUP PLC, BVF INC/IL, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, Laurion Capital Management LP, JACOBS LEVY EQUITY MANAGEMENT, INC, and Schonfeld Strategic Advisors LLC.
This page lists
73
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
85
Q2 2024 holders
73
Holder diff
-12
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.